Repeated SARS-CoV-2 vaccination in cancer patients treated with immune checkpoint inhibitors: induction of high-avidity anti-RBD neutralizing antibodies.

Caruso, Teresita; Salani, Francesca; Catanese, Silvia; Pratesi, Federico; Mercinelli, Chiara; Motta, Giuseppe; Genovesi, Virginia; Bonato, Adele; Sara, Galimberti; Masi, Gianluca; Migliorini, Paola

Caruso, Teresita; Salani, Francesca; Catanese, Silvia; Pratesi, Federico; Mercinelli, Chiara; Motta, Giuseppe; Genovesi, Virginia; Bonato, Adele; Sara, Galimberti; Masi, Gianluca; Migliorini, Paola.

Afiliação

Caruso T; Clinical Immunology and Allergy Unit, Department of Clinical and Experimental Medicine, University of Pisa, Via Roma, 67, 56126, Pisa, Italy.
Salani F; Oncology Unit, Azienda Ospedaliera Universitaria Pisana, Pisa, Italy.
Catanese S; Sant'Anna School of Advanced Studies, Pisa, Italy.
Pratesi F; Department of Translational Medicine and New Technologies for Medicine and Surgery, University of Pisa, Pisa, Italy.
Mercinelli C; Clinical Immunology and Allergy Unit, Department of Clinical and Experimental Medicine, University of Pisa, Via Roma, 67, 56126, Pisa, Italy.
Motta G; Oncology Unit, Azienda Ospedaliera Universitaria Pisana, Pisa, Italy.
Genovesi V; Clinical Immunology and Allergy Unit, Department of Clinical and Experimental Medicine, University of Pisa, Via Roma, 67, 56126, Pisa, Italy.
Bonato A; Oncology Unit, Azienda Ospedaliera Universitaria Pisana, Pisa, Italy.
Sara G; Oncology Unit, Azienda Ospedaliera Universitaria Pisana, Pisa, Italy.
Masi G; Hematology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Migliorini P; Department of Translational Medicine and New Technologies for Medicine and Surgery, University of Pisa, Pisa, Italy.

Int J Clin Oncol ; 28(3): 363-369, 2023 Mar.

Article em En | MEDLINE | ID: mdl-36689013

Assuntos

COVID-19; Neoplasias; Humanos; Inibidores de Checkpoint Imunológico; Vacinas contra COVID-19/uso terapêutico; SARS-CoV-2; COVID-19/prevenção & controle; Vacinação; Anticorpos Neutralizantes; Imunoglobulina A; Imunoglobulina G; Imunoglobulina M; Anticorpos Antivirais; Neoplasias/tratamento farmacológico

Palavras-chave

Anti-Spike antibodies; Antibody avidity; Immune Checkpoint inhibitors; MRNA vaccine; Neutralizing antibodies; SARS-CoV-2

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 / Neoplasias Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google